These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1546548)

  • 21. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
    Laursen TM; Agerbo E; Pedersen CB
    J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.
    Schwartz JE; Fennig S; Tanenberg-Karant M; Carlson G; Craig T; Galambos N; Lavelle J; Bromet EJ
    Arch Gen Psychiatry; 2000 Jun; 57(6):593-600. PubMed ID: 10839338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comorbidity of Axis I and II mental disorders with schizophrenia and psychotic disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    McMillan KA; Enns MW; Cox BJ; Sareen J
    Can J Psychiatry; 2009 Jul; 54(7):477-86. PubMed ID: 19660170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.
    Pini S; Cassano GB; Dell'Osso L; Amador XF
    Am J Psychiatry; 2001 Jan; 158(1):122-5. PubMed ID: 11136644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suicide attempts in major affective disorder patients with comorbid substance use disorders.
    Tondo L; Baldessarini RJ; Hennen J; Minnai GP; Salis P; Scamonatti L; Masia M; Ghiani C; Mannu P
    J Clin Psychiatry; 1999; 60 Suppl 2():63-9; discussion 75-6, 113-6. PubMed ID: 10073390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endogenous affective disorder, seasons of birth and photoperiodicity].
    Brochard A; Escande M; Schmitt L; Granier F; Girard M; Charlet JP; Moron P
    Encephale; 1994; 20(5):459-72. PubMed ID: 7828508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of patterns of substance abuse among patients with schizophrenia.
    Cuffel BJ; Heithoff KA; Lawson W
    Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of course in patients with a cross-sectional diagnosis of schizoaffective disorder.
    Maj M; Perris C
    J Affect Disord; 1990 Oct; 20(2):71-7. PubMed ID: 2148330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
    Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizophrenia and substance abuse: prevalence issues.
    el-Guebaly N; Hodgins DC
    Can J Psychiatry; 1992 Dec; 37(10):704-10. PubMed ID: 1473076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia.
    Lysaker P; Bell M; Beam-Goulet J; Milstein R
    J Nerv Ment Dis; 1994 Feb; 182(2):109-12. PubMed ID: 8308528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA; Luckenbaugh DA; Altshuler LL; Suppes T; McElroy SL; Frye MA; Kupka RW; Keck PE; Leverich GS; Post RM
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders.
    Grossman LS; Harrow M; Goldberg JF; Fichtner CG
    Am J Psychiatry; 1991 Oct; 148(10):1359-65. PubMed ID: 1897617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates and correlates of suicide attempts in first-admission psychotic patients.
    Cohen S; Lavelle J; Rich CL; Bromet E
    Acta Psychiatr Scand; 1994 Sep; 90(3):167-71. PubMed ID: 7810339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing predictive factors for extended hospitalization at acute psychiatric admission.
    Hopko DR; Lachar D; Bailley SE; Varner RV
    Psychiatr Serv; 2001 Oct; 52(10):1367-73. PubMed ID: 11585954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the ICD-10 diagnostic subtype of depression in bipolar disorder compared to recurrent depressive disorder.
    Kessing LV; Jensen HM; Christensen EM
    Psychopathology; 2008; 41(3):141-6. PubMed ID: 18187963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of substance abuse in schizophrenia: nature and significance.
    DeQuardo JR; Carpenter CF; Tandon R
    J Psychiatr Res; 1994; 28(3):267-75. PubMed ID: 7932286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.